Despite strict conditions for those who can get it, the use of diabetes drugs such as Ozempic increases sharply. They now cost the health insurance policy almost 76 million euros per year. “We are only at the start of the Ozempic explosion,” the newspapers write “De Tijd” and “L’Echo”. RIZIV spending is rising by a quarter.

ttn-3